健康体检服务

Search documents
美年健康: 广州花都区美年大健康管理有限公司审计报告
Zheng Quan Zhi Xing· 2025-07-11 13:13
? ? ? ? ? ???? ? ? ? ? ? ? 9 ? ? ? ? ? " .. * . ! #$%&'() +,- ./? 0? ? ~ ? ? ? ? ? ? ? ? ???? l ? ? ? 12 !"#$%&'()*+, -./01 "#2 34356 RST? # 6A99; #B; 9#B ? ? \qrSs`2t12ab <1Ss`2ty ???b6 ??? "#6??v ? ??Z ?<12????};??<6V?512???? ??T? r. ? ? ","#( -./01'( 2 ?z\^_`2ab ???E+ghi6??2;uvp¤??§<"|?f6-?3435??X???®? °±?? Xef3435?6'( ?z?? "#<·?lm??6???·?lmPQ< ?? ??? 6???·?lm??6??'( 2??? "#;???m???? ?E? ?( ?z?? "#<3434??T? ? ? ? ? ? ?? 3 !"#$%& '(#3)*+,- ./012341256 12347+,-. 89: -./;0 <-.=>12? (@AB 12 CD'(#3 EF < !"#$% ...
美年健康集团携手北京大学医学部 打造一流医学研究和应用平台
Cai Jing Wang· 2025-07-09 13:32
Group 1 - The Second China Health Promotion Conference will be held in Shanghai on June 14-15, 2025, organized by the China Health Promotion and Education Association [1] - A strategic cooperation agreement was renewed between Meinian Health Group and Peking University Health Science Center, aiming to establish a long-term partnership based on mutual benefits and resource sharing [1][2] - The cooperation will focus on building the Peking University Meinian Public Health Research Institute and enhancing data collaboration and research outcomes [2][3] Group 2 - The partnership will involve three major areas: co-establishing the Meinian Public Health Research Institute, collaborating on public health and preventive medicine, and conducting personnel exchange and training [2] - The Meinian Public Health Research Institute was established in 2018, focusing on data governance and analysis to support public health initiatives [3] - The institute has developed a multimodal database and published annual health examination big data blue books, contributing significantly to public health and disease prevention in China [3]
趋势研判!2025年中国健康管理行业全景分析:市场规模将达到13225.5亿元,具有巨大的市场需求潜力,行业发展前景广阔[图]
Chan Ye Xin Xi Wang· 2025-07-03 01:49
Core Viewpoint - The health management industry in China has shown significant growth over the past two decades, with increasing market demand driven by the public's awareness and self-management of health. The market size is projected to reach 12,555.2 billion yuan in 2024 and approximately 13,225.5 billion yuan in 2025, indicating a robust growth trajectory [1][6][21]. Industry Definition and Necessity - Health management is defined as a comprehensive monitoring and evaluation of individual or group health, providing consultation and intervention to improve health levels. It originated in the late 1950s in the United States, focusing on controlling disease occurrence and reducing medical expenses [2][3][4]. Current Development Status - The health management industry in China has achieved remarkable results, with a projected market size of 12,555.2 billion yuan in 2024, and expected growth to 13,225.5 billion yuan in 2025. The demand for health management services continues to rise as public awareness increases [6][8]. Market Structure - In 2024, the health management market structure is expected to consist of 20.58% from health check-ups, 74.48% from health insurance premiums, and 4.94% from other services. By 2025, these figures are projected to shift to 21.38%, 73.18%, and 5.44%, respectively [8]. Industry Chain - The health management industry chain includes upstream suppliers of software, medical devices, and health monitoring tools, midstream health check-up institutions, and downstream health consulting services targeting individuals, corporate employees, and government agencies [10]. Development Environment and Policies - The concept of health management was introduced in China in the late 20th century, gaining traction with government initiatives like the "Healthy China 2020" strategy. Various policies have been implemented to support the development of the health management industry, emphasizing the importance of health services in economic transformation [12][14]. Competitive Landscape - The health management industry in China is characterized by intense competition, with major players including Meinian Health, Ruici Medical, and various tech companies like Xiaomi and Huawei. The market is diverse, catering to different demographic groups and health management needs [15][17]. Key Companies - Meinian Health focuses on health check-ups and integrates health consulting and intervention services, achieving a revenue of 10.702 billion yuan and a net profit of 282 million yuan in 2024 [17]. - Ruici Medical, a leading health check-up chain, reported a revenue of 2.924 billion yuan and a net profit of 297 million yuan in 2024, emphasizing customized health check-up services [19]. Development Recommendations - The health management industry should focus on building a comprehensive system that includes public hospitals, private chains, and online platforms to enhance service delivery. There is a need for specialized talent in health management, and public awareness campaigns should be intensified to promote health management practices [21][22][25].
美年大健康产业控股股份有限公司2024年年度分红派息实施公告
Shang Hai Zheng Quan Bao· 2025-06-27 21:30
Group 1 - The core point of the announcement is the approval of the 2024 annual dividend distribution plan by the company's shareholders, which includes a cash dividend of 0.135 yuan per 10 shares, totaling approximately 52.84 million yuan [1][5][3] - The dividend distribution is based on the company's total share capital of 3,914,253,923 shares, and there will be no capital reserve conversion or bonus shares issued [1][5] - The dividend will be distributed to all shareholders registered by the close of trading on July 3, 2025, with the ex-dividend date set for July 4, 2025 [6][7] Group 2 - The company has confirmed that there will be no changes to the total share capital from the announcement of the dividend plan until its implementation [2] - The distribution method involves direct transfer of cash dividends to shareholders' accounts through their securities companies on the ex-dividend date [8] - The company will adjust the exercise price of its stock option incentive plan according to the distribution of dividends, following relevant legal and regulatory procedures [9] Group 3 - The company has provided guarantees for its subsidiaries, with a total financing guarantee limit of up to 4.9 billion yuan approved by the board and shareholders [13] - Recent agreements include a maximum guarantee of 10 million yuan for Guangzhou Meinian Health Medical Clinic Co., Ltd. with Huaxia Bank [14] - Additional guarantees have been signed with various banks for different subsidiaries, including amounts of 1 million yuan to 7 million yuan for several entities [15][16][67]